BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study
Titel:
BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study
Auteur:
Zuckerman, Tsila Ram, Ron Akria, Luiza Koren-Michowitz, Maya Hoffman, Ron Henig, Israel Lavi, Noa Ofran, Yishai Horowitz, Netanel A. Nudelman, Olga Tavor, Sigal Yeganeh, Shay Gengrinovitch, Stela Flaishon, Liat Tessler, Shoshi Ben Yakar, Ruth Rowe, Jacob M.